L-Cysteine HCl Injection Rx
Generic Name and Formulations:
L-Cysteine HCl 50mg/mL; soln for IV infusion after dilution; contains aluminum, sulfur; preservative-free.
Indications for L-Cysteine HCl Injection:
An additive to crystalline amino acid injections to meet essential nutritional requirements for infants given TPNs.
See literature. Rotate inj site. Give by central venous infusion. Add 0.5g L-Cysteine with 12.5g crystalline amino acid injection; dilute as indicated.
Hepatic coma. Metabolic disorders (eg, impaired nitrogen utilization).
Hepatic, renal, pulmonary, or cardiac insufficiency. Hyperkalemia. Metabolic or respiratory alkalosis. Monitor hepatic and renal function; discontinue if BUN levels exceed normal postprandial limits and continue to rise. Monitor blood (eg, CBC, ammonia, glucose, electrolytes, cholesterol, acid-base balance, serum proteins, osmolarity), urine osmolarity and glucose during therapy. Premature neonates. Pregnancy.
Concomitant tetracycline reduces nitrogen sparing effects.
Local reactions (eg, warm sensation, erythema, phlebitis, thrombosis), flushing, fever, nausea.
Single-dose vials (10mL)—10
Psychiatry Advisor Articles
- Continuing Research, Emerging Treatments Hold Promise for Treating Anorexia Nervosa
- ACOG Update: Marijuana Use Discouraged During Pregnancy, Breastfeeding
- Asenapine Prevents Recurrence of Mood Events in Bipolar Disorder
- Depression Profiles in Patients With Type 1 Diabetes vs Type 2 Diabetes
- Purpose, Questions of Social Interaction Lead Physicians to Delay Retirement
- CBT, Acceptance Commitment Therapy Helpful for Those With Chronic Pain
- Suicidal Behavior, Thoughts Associated With Perfectionist Tendencies
- Depression Reduced by Social Belonging, Feelings of Inclusion
- Sleep Disturbance May Be Causal Factor in Psychotic Experiences
- Is Antidepressant Use in Pregnancy Tied to Psychiatric Disorders in Offspring?
- SSRI Use Associated With Increased Type 2 Diabetes Risk in Young Adults
- Improved Patient-Provider Communication Needed Following Urgent Care Visits
- Cardiovascular Risk Management May Slow Neurocognitive Decline in HIV
- Maintenance rTMS for Treatment-Resistant Depression
- New Study Compares Opioid Dependence Relapse Treatments